MedPath

ICAHN School of Medicine At Mount Sinai

ICAHN School of Medicine At Mount Sinai logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1963-01-01
Employees
5K
Market Cap
-
Website
http://www.mssm.edu

Optimizing Postoperative Cognition the Elderly

Completed
Conditions
POCD
Postoperative Cognitive Dysfunction
Interventions
Procedure: Processed EEG
First Posted Date
2016-01-08
Last Posted Date
2020-03-23
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
178
Registration Number
NCT02650687
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy

Phase 4
Terminated
Conditions
Gastric Bypass
Endoscopy
Obesity
Bariatrics
Sleep Apnea Syndromes
Interventions
Drug: Ketofol
Drug: Saline
First Posted Date
2015-12-31
Last Posted Date
2020-02-11
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
22
Registration Number
NCT02643979
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults

Not Applicable
Completed
Conditions
HIV
Interventions
Behavioral: HEP Course
Behavioral: MBSR Course
First Posted Date
2015-12-10
Last Posted Date
2022-05-09
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
84
Registration Number
NCT02626949
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)

Phase 2
Completed
Conditions
Post-operative Excessive Scarring
Interventions
First Posted Date
2015-12-08
Last Posted Date
2020-12-08
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
42
Registration Number
NCT02623829
Locations
🇺🇸

Icahn School of Medicine at Mount Sinia, New York, New York, United States

Precision IFX: Using a Dashboard to Individualize Infliximab Dosage

Not Applicable
Completed
Conditions
Inflammatory Bowel Disease
Interventions
Other: Individualized Dosage Precision IFX Dashboard
First Posted Date
2015-12-08
Last Posted Date
2021-05-18
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
189
Registration Number
NCT02624037
Locations
🇺🇸

Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, New York, New York, United States

A Study of Secukinumab for the Treatment of Alopecia Areata

Phase 2
Terminated
Conditions
Alopecia Areata
Interventions
Drug: Placebo
First Posted Date
2015-11-06
Last Posted Date
2021-03-11
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
11
Registration Number
NCT02599129
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Secukinumab for Treatment of Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Placebo
First Posted Date
2015-11-01
Last Posted Date
2019-06-12
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
41
Registration Number
NCT02594098
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Targeting Platelets in Chronic HIV Infection

Phase 2
Completed
Conditions
HIV-1 Infection
Interventions
First Posted Date
2015-10-19
Last Posted Date
2018-02-28
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
27
Registration Number
NCT02578706
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study

Phase 3
Completed
Conditions
Vascular Inflammation
Atherosclerotic Cardiovascular Disease
Interventions
First Posted Date
2015-10-15
Last Posted Date
2020-04-20
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
123
Registration Number
NCT02576067
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Non Invasive Neuromonitoring After Cardiac Arrest

Completed
Conditions
Cardiac Arrest
Interventions
Device: Non-invasive cerebral flow monitoring
First Posted Date
2015-10-14
Last Posted Date
2017-04-19
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
21
Registration Number
NCT02575196
Locations
🇺🇸

Mount Sinai Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath